Lymphoma News - ScienceDaily
3 days ago · Sep. 8, 2022 — Scientists have completed the largest study of families affected by Hodgkin lymphoma and identified novel variants linked to cancer ...
Nivolumab and AVD the New Standard in Hodgkin Lymphoma
5 days ago · The immunotherapy drug nivolumab (Opdivo) should be part of the initial treatment of teens and adults with advanced forms of classic Hodgkin lymphoma, according to updated results from a large NCI-funded clinical trial.
Immunotherapy improves survival in people with advanced Hodgkin ...
Oct 16, 2024 · An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.
New Combo Drug Therapy Halves Death Risk From Advanced Hodgkin Lymphoma
Oct 16, 2024 · According to Friedberg, who spoke in the University of Rochester interview, progress against Hodgkin lymphoma has been one of cancer research's "greatest success stories."
Hodgkin lymphoma prognosis, biology tracked with circulating …
Dec 11, 2023 · Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.
New Treatment Breakthrough for Advanced Hodgkin's Lymphoma…
5 days ago · In a major development for patients with advanced classic Hodgkin's lymphoma, a large clinical trial has shown that a new treatment combination is more effective and causes fewer side effects than the current standard therapy.
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
Oct 16, 2024 · Incorporating brentuximab vedotin into the treatment of advanced-stage classic Hodgkin’s lymphoma improves outcomes in adult and pediatric patients.
Breakthrough Clinical Trial Reveals Better Treatment for Advanced ...
Oct 18, 2024 · BUFFALO, N.Y., and ATLANTA — New results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma is treated in newly diagnosed adolescents and adults. The details appear in a study published Oct. 16 in The New England Journal of Medicine.
Immunotherapy boosts survival of advanced Hodgkin lymphoma
Oct 17, 2024 · Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.
In Landmark Study, Immunotherapy Boosts Survival of Advanced Hodgkin …
Oct 16, 2024 · A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the disease.